Infectious Disease CRO and Vaccine Expertise
Expertise That Fits Your Clinical Trial
Because we have therapeutically aligned project teams, your clinical trial receives attention from experts who understand the unique needs of studies conducted in infectious disease clinical trials and vaccines. We are not guessing how to support your sites and patients, we know how because of our experienced staff. At Pharm-Olam, 79% of our CRAs and 84% of our project managers have specialized infectious disease and vaccine experience. We are not only experts in our field, we are experts in your clinical trial.
Deep Roots in Antibiotic Research:
As Infectious Disease CRO, we have expansive infectious disease experience, but especially deep roots in supporting anti-infective development. Our long and successful history in the anti-infective area of drug development, is demonstrated by supporting more than 50% of all antibiotics approved by FDA/EMA since 2010.
What’s more, we have executed numerous pivotal studies supporting marketing approvals for the following indications, to name a few:
- 3 compounds for acute bacterial skin and skin structure infections
- 3 compounds for pneumonia – community acquired and nosocomial (ventilator associated, and hospital acquired)
- 1 compound for Urinary tract infections